(Q48725144)

15 February 2018

title

Enhancement of the anti-immobility action of antidepressants by risperidone in the forced swimming test in mice. (English)

1 reference

15 February 2018

1 reference

1

Zofia Rogóż

1 reference

15 February 2018

Marcin Kabziński

2

1 reference

15 February 2018

publication date

1 January 2011

1 reference

15 February 2018

published in

Pharmacological Reports

1 reference

15 February 2018

volume

63

1 reference

15 February 2018

issue

6

1 reference

15 February 2018

page(s)

1533-1538

1 reference

15 February 2018

Treatment algorithms in treatment-resistant depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Concomitant use of carbamazepine and olanzapine and the effect on some behavioral functions in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Potentiation of the antidepressant-like effect of desipramine or reboxetine by metyrapone in the forced swimming test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970717-4

7 January 2021

10.1016/S1734-1140(11)70717-4

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018